Changchun High & New Technology Industries Group Inc - Asset Resilience Ratio

Latest as of March 2026: 5.50%

Changchun High & New Technology Industries Group Inc (000661) has an Asset Resilience Ratio of 5.50% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Changchun High & New Technology Industri (000661) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.69 Billion
≈ $247.46 Million USD Cash + Short-term Investments

Total Assets

CN¥30.77 Billion
≈ $4.50 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1996–2025)

This chart shows how Changchun High & New Technology Industries Group Inc's Asset Resilience Ratio has changed over time. See 000661 equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Changchun High & New Technology Industries Group Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000661 market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥1.69 Billion 5.5%
Total Liquid Assets CN¥1.69 Billion 5.50%

Asset Resilience Insights

  • Limited Liquidity: Changchun High & New Technology Industries Group Inc maintains only 5.50% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Changchun High & New Technology Industries Group Inc Industry Peers by Asset Resilience Ratio

Compare Changchun High & New Technology Industries Group Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
Drug Manufacturers - Specialty & Generic 11.60%
SIMCERE PHARMAC. GRP LTD
F:S2P
Drug Manufacturers - Specialty & Generic 0.44%
Curaleaf Holdings Inc.
TO:CURA
Drug Manufacturers - Specialty & Generic 3.73%
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
Drug Manufacturers - Specialty & Generic 24.59%
Walvax BioTech
SHE:300142
Drug Manufacturers - Specialty & Generic 2.20%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%
Renhe Pharmacy Co Ltd
SHE:000650
Drug Manufacturers - Specialty & Generic 37.54%

Annual Asset Resilience Ratio for Changchun High & New Technology Industries Group Inc (1996–2025)

The table below shows the annual Asset Resilience Ratio data for Changchun High & New Technology Industries Group Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 4.76% CN¥1.43 Billion
≈ $209.35 Million
CN¥30.08 Billion
≈ $4.40 Billion
+4.68pp
2024-12-31 0.08% CN¥24.96 Million
≈ $3.65 Million
CN¥31.05 Billion
≈ $4.54 Billion
+0.05pp
2023-12-31 0.03% CN¥9.96 Million
≈ $1.46 Million
CN¥30.74 Billion
≈ $4.50 Billion
+0.39pp
2022-12-31 -0.36% CN¥-93.39 Million
≈ $-13.67 Million
CN¥26.03 Billion
≈ $3.81 Billion
+0.22pp
2021-12-31 -0.57% CN¥-129.31 Million
≈ $-18.92 Million
CN¥22.52 Billion
≈ $3.29 Billion
-0.64pp
2020-12-31 0.06% CN¥10.28 Million
≈ $1.50 Million
CN¥16.91 Billion
≈ $2.47 Billion
-1.64pp
2019-12-31 1.70% CN¥215.86 Million
≈ $31.59 Million
CN¥12.72 Billion
≈ $1.86 Billion
-4.72pp
2018-12-31 6.41% CN¥605.00 Million
≈ $88.53 Million
CN¥9.43 Billion
≈ $1.38 Billion
-6.78pp
2017-12-31 13.19% CN¥970.00 Million
≈ $141.94 Million
CN¥7.35 Billion
≈ $1.08 Billion
-10.82pp
2016-12-31 24.02% CN¥1.49 Billion
≈ $218.03 Million
CN¥6.20 Billion
≈ $907.77 Million
+25.43pp
2015-12-31 -1.41% CN¥-53.95 Million
≈ $-7.89 Million
CN¥3.82 Billion
≈ $558.33 Million
-1.42pp
2014-12-31 0.01% CN¥179.55K
≈ $26.27K
CN¥3.15 Billion
≈ $460.71 Million
+4.31pp
2008-12-31 -4.30% CN¥-66.57 Million
≈ $-9.74 Million
CN¥1.55 Billion
≈ $226.45 Million
+0.75pp
2007-12-31 -5.05% CN¥-76.39 Million
≈ $-11.18 Million
CN¥1.51 Billion
≈ $221.22 Million
-5.07pp
2005-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.41 Billion
≈ $206.88 Million
0.00pp
2004-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.39 Billion
≈ $203.99 Million
+0.00pp
2003-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.55 Billion
≈ $226.98 Million
-0.01pp
2002-12-31 0.02% CN¥300.00K
≈ $43.90K
CN¥1.22 Billion
≈ $178.72 Million
+0.02pp
1998-12-31 0.01% CN¥87.65K
≈ $12.83K
CN¥1.30 Billion
≈ $190.46 Million
-0.54pp
1996-12-31 0.54% CN¥4.00 Million
≈ $584.70K
CN¥737.35 Million
≈ $107.90 Million
--
pp = percentage points

About Changchun High & New Technology Industries Group Inc

SHE:000661 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.83 Billion
CN¥26.15 Billion CNY
Market Cap Rank
#4307 Global
#717 in China
Share Price
CN¥64.10
Change (1 day)
+0.49%
52-Week Range
CN¥63.79 - CN¥136.30
All Time High
CN¥1174.87
About

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers recombinant human growth hormone injection; recombinant human follicle stimulating hormone for injection; herpes zoster vaccines; live attenuated varicella vaccine; freeze-dried nasa… Read more